AirSculpt Technologies, Inc. AIRS

AIRS Company Overview

AirSculpt Technologies, Inc. is a U.S.-based cosmetic surgery and body contouring company that operates through a network of proprietary treatment centers branded as AirSculpt®. The company specializes in minimally invasive body sculpting procedures using its patented and trademarked fat removal and fat transfer technologies. AIRS operates within the elective medical aesthetics and cosmetic surgery industry, serving consumers seeking body contouring, fat reduction, skin tightening, and related aesthetic enhancement procedures.

The company’s primary revenue drivers are patient procedure fees generated through its owned and operated centers, with additional revenue derived from complementary aesthetic services and financing arrangements. AIRS markets its procedures as alternatives to traditional liposuction, emphasizing reduced downtime, local anesthesia, and minimally invasive techniques. The company traces its origins to physician-led cosmetic surgery operations founded by Dr. Aaron Rollins, who developed the AirSculpt methodology and expanded the business into a branded national platform. Following years of private expansion, the company became publicly traded on Nasdaq under the ticker AIRS in 2021.